World Lung Updates on Unmet Needs in EGFRm NSCLC

 

World Lung Updates on Unmet Needs in EGFRm NSCLC
09:29

University of Colorado Cancer Center

mNSCLC Treatment: How Critical Is Molecular Profiling for Targeted Therapy Selection?

FEATURING Tejas Patil
  • 684 views
  • November 25, 2020
  • 3
09:00

Lung Cancer Europe (LuCE)

2020 ESMO Update on Advanced EGFR-Mutated NSCLC: Mobocertinib (TAK-788), HER3-Directed ADC Patritumab Deruxtecan, EGFR-MET Bispecific Antibody Amivantamab + Lazertinib (3rd Gen TKI)

FEATURING Sanjay Popat
  • 356 views
  • November 26, 2020
  • 4
28:45

ecancer

ESMO 2020 Expert Discussion on EGFR Exon 20 Insertions in NSCLC: What Are the Available Drugs and How Effective & Tolerable Are They?

FEATURING Alex Spira, Benjamin Besse, Antonio Passaro, Michael Thomas
  • 633 views
  • January 11, 2021
  • 2
13:52

2020 ASCO Virtual Direct™ Highlights

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dxd in HER2m Disease, Assessing Efficacy of Treatment Options in EGFRm Disease

FEATURING Ibiayi Dagogo-Jack
  • 318 views
  • January 28, 2021
  • 3
15:35

ecancer

Expert Discussion on EGFRm NSCLC: What Are the Latest Developments?

FEATURING Alex Spira
  • 401 views
  • September 22, 2020
  • 2
09:34

Lung Cancer Europe (LuCE)

EGFR Mutations in mNSCLC: 1L TKI Inhibitors, Molecular Resistance Mechanism and Implication for Next Line Therapy, Role of ctDNA, EGFRi Efficacy

FEATURING Rolf A. Stahel
  • 268 views
  • January 21, 2021
14:45

Jordi Remon Masip

Advanced NSCLC With EGFR Exon 20 Insertions: What Is the Importance of EGFR ex20ins? How Relevant Are the New Agents Mobocertinib & Amivantamab?

  • 583 views
  • February 23, 2021
  • 3
07:40

Nicolas Girard

2020 WCLC Update on Comparative Clinical Outcomes in EGFRm NSCLC: What Are the Prognostic/Predictive Values of Exon20ins vs. cEGFR?

  • 50 views
  • February 23, 2021
12:18

Santiago Viteri

WCLC Update on Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants in NSCLC: Estimates From NGS-Based Real-World Datasets

  • 382 views
  • March 19, 2021
  • 1